Catalyst Pharmaceuticals, Inc.
CPRX
$31.16
$0.020.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 63.73M | 52.70M | 52.78M | 52.11M | 56.74M |
| Total Depreciation and Amortization | 9.77M | 9.54M | 9.42M | 9.46M | 9.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -884.00K | -2.18M | 9.86M | 8.78M | 897.00K |
| Change in Net Operating Assets | -13.04M | -15.17M | -39.62M | 946.00K | -7.05M |
| Cash from Operations | 59.59M | 44.89M | 32.44M | 71.30M | 60.04M |
| Capital Expenditure | -27.00K | -32.00K | 0.00 | -26.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -27.00K | -32.00K | 0.00 | -26.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.30M | 1.88M | 5.80M | 2.21M | 4.79M |
| Repurchase of Common Stock | -14.88M | -26.21M | 0.00 | -219.00K | -642.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.30M | -1.24M | -1.14M | -1.12M | -1.09M |
| Cash from Financing | -12.87M | -25.58M | 4.65M | 872.00K | 3.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.69M | 19.28M | 37.09M | 72.14M | 63.10M |